Dr. Emad Dawoud
09:45 –10:30
Friday 3-5-2024 Day 1
Role of anthracyclines in early breast cancer
- When to omit anthracyclines in(neo) adjuvant therapy of HER2-negative breast cancer
When to use anthracyclines in (neo) adjuvant therapy of HER2-positive breast cancer
Moderator:
Dr. Meteeb Alfohaidi
Panel:
09:00-09:45
Saturday 4-5-2024 Day 2
Pancreatic cancer
- Neoadjuvant therapy in resectable/borderline resectable pancreatic cancer
- Best neoadjuvant strategy
- 1st line and subsequent therapies in pancreatic cancer: Doublet vs Triplets
- biomarkers for metastatic patients
Moderator: 
Dr. Abdullah Alsharm
Panel:
11:30-12:15
Saturday 4-5-2024 Day 2
Challenges and dynamics of oncology health care
- Financial toxicities and economic burden
- Delayed access to oncology care
- Cancer survivors: challenges and special requirements
- Integration of service with primary health care for cancer survivors
Moderator: 
Dr. Esam Murshid
Panel:
